Exact Sciences Corp (NAS:EXAS)
$ 45.55 2.1 (4.83%) Market Cap: 8.41 Bil Enterprise Value: 9.92 Bil PE Ratio: 0 PB Ratio: 2.67 GF Score: 75/100

Exact Sciences Corp at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 04:50PM GMT
Release Date Price: $136.39 (-2.72%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. Good morning, everybody. My name is Doug Schenkel from the Cowen Life Science and Diagnostic Tools team. It's my pleasure to welcome you to the 41st Annual Cowen and Company Health Care Conference, and also to welcome you to this session specifically with Exact Sciences' Chairman and Chief Executive Officer, Kevin Conroy; and the company's Chief Financial Officer, Jeff Elliott. Thanks to the 2 of you for being with us today.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Hi, Doug. Thanks for having us.

Questions & Answers

Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So I wanted to start on the topic of strategic positioning and strategic evaluation. And I don't think any of us technically thought of Exact being a 1-product company for the last few years, but I think it was kind of viewed that way by many, for good or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot